http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#head http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#assertion http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#provenance http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#assertion http://rdf.disgenet.org/resource/gda/DGNa2842605266c12cc1edf6503fa9f3ac4 http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/1956 http://rdf.disgenet.org/resource/gda/DGNa2842605266c12cc1edf6503fa9f3ac4 http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C0001418 http://rdf.disgenet.org/resource/gda/DGNa2842605266c12cc1edf6503fa9f3ac4 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001122 http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#provenance http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#assertion http://purl.org/dc/terms/description [The major recommendations are to use testing for EGFR mutations and ALK fusions to guide patient selection for therapy with an epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) inhibitor, respectively, in all patients with advanced-stage adenocarcinoma, regardless of sex, race, smoking history, or other clinical risk factors, and to prioritize EGFR and ALK testing over other molecular predictive tests.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/23551194 http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU http://purl.org/dc/terms/created 2017-10-17T13:12:14+02:00 http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0